1 H and 13 C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1 H MRS study of human high grade gliomas

High-resolution magic angle spinning (HR-MAS) oneand two-dimensional H and C nuclear magnetic resonance (NMR) spectroscopy has been used to study intact glioblastoma (GBM) brain tumour tissue. The results were compared with in vitro chemical extract and in vivo spectra. The resolution of H one-dimensional, H TOCSY and C HSQC HR-MAS spectra is comparable to that obtained on perchloric extracts. C HSQC HR-MAS spectra have been particularly useful for the identification of 37 different metabolites in intact biopsy tumours, excluding water and DSS components. To our knowledge, this is the most detailed assignment of biochemical compounds obtained in intact human tissue, in particular in brain tumour tissue. Tissue degradation during the recording of the NMR experiment was avoided by keeping the sample at a temperature of 4 C. Detailed metabolical compositions of 10 GBM (six primary, two secondary and two unclassified) were obtained. A good correlation between ex vivo and in vivo MRS has been found. Copyright # 2004 John Wiley & Sons, Ltd.

[1]  J R Griffiths,et al.  Pattern recognition analysis of 1H NMR spectra from perchloric acid extracts of human brain tumor biopsies , 1998, Magnetic resonance in medicine.

[2]  Paul A. Bottomley,et al.  4480228 Selective volume method for performing localized NMR spectroscopy , 1985 .

[3]  J. Roda,et al.  Diagnóstico diferencial de tumores cerebrales “in vitro” por espectroscopía de resonancia magnética de protón. Método de los cocientes espectrales , 1998 .

[4]  Irina Mader,et al.  Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors , 1996, Magnetic Resonance Materials in Physics, Biology and Medicine.

[5]  M. Spraul,et al.  750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. , 1995, Analytical chemistry.

[6]  D. Hoffmann,et al.  Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spectroscopy--initial results. , 1999, Radiology.

[7]  T. Fan.  Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures , 1996 .

[8]  Leo L. Cheng,et al.  Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. , 2000, Neuro-oncology.

[9]  B. Sitter,et al.  High‐resolution magic angle spinning MRS of breast cancer tissue , 2002, NMR in biomedicine.

[10]  Ian C. P. Smith,et al.  1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.

[11]  S. Holtås,et al.  Proton magnetic resonance spectroscopy in brain tumours: clinical applications , 2001, Neuroradiology.

[12]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[13]  R. Gonzalez,et al.  Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. , 1998, Cancer research.

[14]  G. Montelione,et al.  Total Correlation Spectroscopy (TOCSY) of Proteins Using Coaddition of Spectra Recorded with Several Mixing Times , 1993 .

[15]  R. Gonzalez,et al.  Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D Riddoch,et al.  Neoplasms of the central nervous system. , 1977, The Practitioner.

[17]  J. Lindon,et al.  600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. , 1993, Journal of pharmaceutical and biomedical analysis.

[18]  M. Rijpkema,et al.  Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging , 2003, NMR in biomedicine.

[19]  J K Smith,et al.  Correlation of myo-inositol levels and grading of cerebral astrocytomas. , 2000, AJNR. American journal of neuroradiology.

[20]  Brian D. Ross,et al.  Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases , 1999 .

[21]  D. Lilley,et al.  Carbon-13-NMR of peptides and proteins , 1978 .

[22]  Brian Ross.  Basic Physics of MRS , 1999 .

[23]  M. C. Martínez-Bisbal,et al.  Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis , 2003, Journal of Neurology.

[24]  S. Shibata,et al.  Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain , 2001, Neuroradiology.

[25]  G. Sutherland,et al.  Mobile lipids and metabolic heterogeneity of brain tumours as detectable by Ex Vivo 1H MR spectroscopy , 1994, NMR in biomedicine.

[26]  D. Wishart,et al.  The 13C Chemical-Shift Index: A simple method for the identification of protein secondary structure using 13C chemical-shift data , 1994, Journal of biomolecular NMR.

[27]  A. Polednak,et al.  Brain, other central nervous system, and eye cancer , 1995, Cancer.

[28]  Carles Arús,et al.  Automated classification of short echo time in in vivo 1H brain tumor spectra: A multicenter study , 2003, Magnetic resonance in medicine.

[29]  M. Castillo,et al.  Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors. , 1999, Topics in magnetic resonance imaging : TMRI.